139 related articles for article (PubMed ID: 6135335)
1. Simultaneous application of influenza chemovaccine and "Vaxigrip" preparations with BCG.
Zykov MP; Subbotina TI; Rudenko LG; Kaplin NN
Acta Virol; 1983 Mar; 27(2):160-7. PubMed ID: 6135335
[TBL] [Abstract][Full Text] [Related]
2. BCG vaccine responses following simultaneous immunization against influenza and tuberculosis. 2nd report.
Zykov MP; Subbotina TI; Kaplin NN
Z Erkr Atmungsorgane; 1981 May; 157(2):165-80. PubMed ID: 6797135
[TBL] [Abstract][Full Text] [Related]
3. Influenza vaccine response following its simultaneous application with BCG 1st report.
Zykov MP; Raphaelskaya TI
Z Erkr Atmungsorgane; 1981; 156(3):203-11. PubMed ID: 7293275
[TBL] [Abstract][Full Text] [Related]
4. Modulation of humoral immune response to influenza vaccines by BCG.
Zykov MP; Subbotina TI
Acta Virol; 1985 Sep; 29(5):403-9. PubMed ID: 2866694
[TBL] [Abstract][Full Text] [Related]
5. Antibody formation in laboratory animals after parenteral application of A/swine influenza virus.
Dolezalová B; Závadová H; Stárek M; Vonka V
Dev Biol Stand; 1977 Jun 1-3; 39():405-8. PubMed ID: 604122
[TBL] [Abstract][Full Text] [Related]
6. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
7. Induction of immunity by DNA vaccination: application to influenza and tuberculosis.
Ulmer JB; Deck RR; DeWitt CM; Donnelly JJ; Friedman A; Montgomery DL; Yawman AM; Orme IM; Denis O; Content J; Huygen K; Liu MA
Behring Inst Mitt; 1997 Feb; (98):79-86. PubMed ID: 9382773
[TBL] [Abstract][Full Text] [Related]
8. Failure of protection and enhanced pneumonia with a US H1N2 swine influenza virus in pigs vaccinated with an inactivated classical swine H1N1 vaccine.
Vincent AL; Lager KM; Janke BH; Gramer MR; Richt JA
Vet Microbiol; 2008 Jan; 126(4):310-23. PubMed ID: 17719188
[TBL] [Abstract][Full Text] [Related]
9. [Hopeful vaccines: influenza and tuberculosis in reverse].
Nau JY
Rev Med Suisse; 2013 Feb; 9(373):386-7. PubMed ID: 23477075
[No Abstract] [Full Text] [Related]
10. Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system.
Brett IC; Johansson BE
Virology; 2005 Sep; 339(2):273-80. PubMed ID: 15996702
[TBL] [Abstract][Full Text] [Related]
11. [Selection of the influenza virus vaccinal strain by means of crossed protection experiments on mice].
Briantseva EA
Tr Inst Im Pastera; 1976; 47():19-23. PubMed ID: 1088724
[No Abstract] [Full Text] [Related]
12. Protective efficacy of intranasal vaccination with Mycobacterium bovis BCG against airway Mycobacterium tuberculosis challenge in mice.
Giri PK; Verma I; Khuller GK
J Infect; 2006 Nov; 53(5):350-6. PubMed ID: 16442629
[TBL] [Abstract][Full Text] [Related]
13. BCG vaccine elicits both T-cell mediated and humoral immune responses directed against mycobacterial lipid components.
Watanabe Y; Watari E; Matsunaga I; Hiromatsu K; Dascher CC; Kawashima T; Norose Y; Shimizu K; Takahashi H; Yano I; Sugita M
Vaccine; 2006 Jul; 24(29-30):5700-7. PubMed ID: 16725232
[TBL] [Abstract][Full Text] [Related]
14. Influenza hemagglutinin vaccine with poly(gamma-glutamic acid) nanoparticles enhances the protection against influenza virus infection through both humoral and cell-mediated immunity.
Okamoto S; Yoshii H; Akagi T; Akashi M; Ishikawa T; Okuno Y; Takahashi M; Yamanishi K; Mori Y
Vaccine; 2007 Nov; 25(49):8270-8. PubMed ID: 17977633
[TBL] [Abstract][Full Text] [Related]
15. Subunit influenza vaccine and its testing in clinical immunology.
Zykov MP; Rudenko LG; Zoshchenkova NY; Rafael'skaya TI
J Hyg Epidemiol Microbiol Immunol; 1980; 24(2):212-8. PubMed ID: 6997374
[TBL] [Abstract][Full Text] [Related]
16. Vaccine-preventable influenza disease burden from clinical trials of Vaxigrip - an inactivated split virion influenza vaccine - supports wider vaccine use.
Arnoux S; Weinberger C; Gessner BD
Vaccine; 2007 Nov; 25(45):7720-31. PubMed ID: 17920168
[TBL] [Abstract][Full Text] [Related]
17. Protective efficacy of recombinant (Ag85A) BCG Tokyo with Ag85A peptide boosting against Mycobacterium tuberculosis-infected guinea pigs in comparison with that of DNA vaccine encoding Ag85A.
Sugawara I; Udagawa T; Taniyama T
Tuberculosis (Edinb); 2007 Mar; 87(2):94-101. PubMed ID: 16815096
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of live tuberculosis vaccines after presensitization with Mycobacterium avium.
de Lisle GW; Wards BJ; Buddle BM; Collins DM
Tuberculosis (Edinb); 2005; 85(1-2):73-9. PubMed ID: 15687030
[TBL] [Abstract][Full Text] [Related]
19. [Sensitization to the influenza virus in a combined experimental infection].
Gönczi S
Biull Eksp Biol Med; 1987 May; 103(5):603-6. PubMed ID: 3496128
[TBL] [Abstract][Full Text] [Related]
20. Transcutaneous immunization with inactivated influenza virus induces protective immune responses.
Skountzou I; Quan FS; Jacob J; Compans RW; Kang SM
Vaccine; 2006 Aug; 24(35-36):6110-9. PubMed ID: 16766095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
